{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:10:00Z","timestamp":1770509400094,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1097\/igc.0b013e3182929056","type":"journal-article","created":{"date-parts":[[2013,5,21]],"date-time":"2013-05-21T13:40:30Z","timestamp":1369143630000},"page":"797-802","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Expression of Epithelial Cell Adhesion Molecule in Paired Tumor Samples of Patients With Primary and Recurrent Serous Ovarian Cancer"],"prefix":"10.1016","volume":"23","author":[{"given":"Pietzner","family":"Klaus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woopen","family":"Hannah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richter","family":"Rolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joens","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Braicu","family":"Elena Ioana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrova","family":"Desislava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mellstedt","family":"H\u00e5kan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darb-Esfahani","family":"Silvia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denkert","family":"Carsten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindhofer","family":"Horst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fotopoulou","family":"Christina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sehouli","family":"Jalid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/IGC.0b013e3182929056_bb0005","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1200\/JCO.2001.19.14.3312","article-title":"Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan","volume":"19","author":"Gordon","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1097\/IGC.0b013e3182929056_bb0010","first-page":"43","article-title":"Cancer statistics, 2007","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"10.1097\/IGC.0b013e3182929056_bb0015","doi-asserted-by":"crossref","first-page":"740472","DOI":"10.1155\/2010\/740472","article-title":"Targeted therapy in ovarian cancer","volume":"2010","author":"Willmott","year":"2010","journal-title":"J Oncol"},{"key":"10.1097\/IGC.0b013e3182929056_bb0020","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/annonc\/mdp314","article-title":"An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer","volume":"21","author":"Schmidt","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1097\/IGC.0b013e3182929056_bb0025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ygyno.2011.06.004","article-title":"Intraperitoneal treatment with the trifunctional bispecif ic antibody catumaxomab in patients with platinum-resistant epithelial ovarian cancer: a phase IIa study of the AGO Study Group","volume":"123","author":"Baumann","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1097\/IGC.0b013e3182929056_bb0030","first-page":"3669","article-title":"Immunohistochemical localization of epithelial glycoprotein EGP-2 and carcinoembryonic antigen in normal colonic mucosa and colorectal tumors","volume":"18","author":"Ogura","year":"1998","journal-title":"Anticancer Res"},{"key":"10.1097\/IGC.0b013e3182929056_bb0035","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/BF01542654","article-title":"Colorectal carcinoma antigens detected by hybridoma antibodies","volume":"5","author":"Koprowski","year":"1979","journal-title":"Somatic Cell Genet"},{"key":"10.1097\/IGC.0b013e3182929056_bb0040","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1093\/carcin\/bgq187","article-title":"EpCAM in carcinogenesis: the good, the bad or the ugly","volume":"31","author":"van der Gun","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1097\/IGC.0b013e3182929056_bb0045","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.4049\/jimmunol.173.2.1023","article-title":"A tumor-associated glycoprotein that blocks MHC class II-dependent antigen presentation by dendritic cells","volume":"17","author":"Gutzmer","year":"2004","journal-title":"J Immunol"},{"key":"10.1097\/IGC.0b013e3182929056_bb0050","doi-asserted-by":"crossref","first-page":"5818","DOI":"10.1158\/0008-5472.CAN-04-0754","article-title":"EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy","volume":"64","author":"Osta","year":"2004","journal-title":"Cancer Res"},{"key":"10.1097\/IGC.0b013e3182929056_bb0055","first-page":"171","article-title":"Prognostic significance of EpCAM expression in human esophageal cancer","volume":"30","author":"Kimura","year":"2007","journal-title":"Int J Oncol"},{"key":"10.1097\/IGC.0b013e3182929056_bb0060","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/S0140-6736(00)03312-2","article-title":"Ep-CAM overexpression in breast cancer as a predictor of survival","volume":"356","author":"Gastl","year":"2000","journal-title":"Lancet"},{"key":"10.1097\/IGC.0b013e3182929056_bb0065","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ygyno.2006.03.035","article-title":"Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer","volume":"103","author":"Spizzo","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1097\/IGC.0b013e3182929056_bb0070","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1158\/1078-0432.CCR-1132-03","article-title":"Epithelial cell adhesion molecule (KSA) expression: pathobiology and its role as an independent predictor of survival in renal cell carcinoma","volume":"10","author":"Seligson","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1097\/IGC.0b013e3182929056_bb0075","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1093\/annonc\/mdr625","article-title":"Phase IB study of the EpCAM antibody adecatumumab combined with docetaxel in patients with EpCAM-positive relapsed or refractory advanced-stage breast cancer","volume":"23","author":"Schmidt","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1097\/IGC.0b013e3182929056_bb0080","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1002\/ijc.25423","article-title":"The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: results of a prospective randomized phase II\/III trial","volume":"127","author":"Heiss","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1097\/IGC.0b013e3182929056_bb0085","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jso.21288","article-title":"Intra-abdominal tumor dissemination pattern and surgical outcome in 214 patients with primary ovarian cancer","volume":"99","author":"Sehouli","year":"2009","journal-title":"J Surg Oncol"},{"key":"10.1097\/IGC.0b013e3182929056_bb0090","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/IGC.0b013e3181a8331f","article-title":"Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent\/chemotherapy-resistant epithelial ovarian cancer: implications for epithelial cell adhesion moleculeYspecific immunotherapy","volume":"19","author":"Bellone","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1097\/IGC.0b013e3182929056_bb0095","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1158\/1078-0432.CCR-03-0528","article-title":"Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival","volume":"10","author":"Varga","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1097\/IGC.0b013e3182929056_bb0100","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/jcp.2011.090274","article-title":"EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis","volume":"64","author":"Spizzo","year":"2011","journal-title":"J Clin Pathol"},{"key":"10.1097\/IGC.0b013e3182929056_bb0105","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/ijc.10443","article-title":"In vitro and in vivo activity of MT201, a fully human monoclonal antibody for pancarcinoma treatment","volume":"100","author":"Naundorf","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1097\/IGC.0b013e3182929056_bb0110","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s00262-007-0310-7","article-title":"Treatment of non-small cell lung cancer patients with the trifunctional monoclonal antibody catumaxomab (anti-EpCAM x anti-CD3): a phase I study","volume":"56","author":"Sebastian","year":"2007","journal-title":"Cancer Immunol Immunother"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24087747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24087747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1097\/IGC.0b013e3182929056","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T12:35:55Z","timestamp":1753101355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24087747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S1048891X24087747"],"URL":"https:\/\/doi.org\/10.1097\/igc.0b013e3182929056","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of Epithelial Cell Adhesion Molecule in Paired Tumor Samples of Patients With Primary and Recurrent Serous Ovarian Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/IGC.0b013e3182929056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright Copyright \u00a9 2013 by IGCS and ESGO.","name":"copyright","label":"Copyright"}]}}